AstraZeneca tops Pharmaceutical Innovation Index

0
A turnaround of AstraZeneca that led to the shedding of thousands of jobs in Delaware remains a work in progress.

But a recently published index indicates the company that razed its labs in Talleyville and moved some jobs to its Medimmuneunit in Maryland is the top innovator in the pharmaceutical industry.

The eighth annual Pharmaceutical Innovation Index, released by IDEA Pharma, puts AstraZeneca top the industry for the first time.

The Pharmaceutical Innovation Index measures, scores and the company’s ability to deliver innovation to patients, by objectively evaluating performance based on a rolling five year period (2012-2017).

AstraZeneca came from the middle of the pack in 2017 to take the 2018 PII crown. Gilead also continued their PII ascent, to second place, advancing from 2017’s 3rd. Johnson & Johnson, having ceded the top spot last year after a four year run on top, was able to regain some of the lost ground in 2018, landing in a joint 3rd spot with a rapidly-improving Novartis.

          Pharmaceutical Innovation Index 2018

                

     PII 2018                            PII 2017      Change

     Ranking         Company Name        Ranking     from 2017

        1       AstraZeneca            15          +14

        2        Gilead                     3            +1

        3        Johnson & Johnson          4            +1

        3        Novartis                   12           +9

        5        AbbVie                     2            -3

        6        Bristol-Myers Squibb       9            +3

        7        Merck & Co                 7        No change

        8        Roche                      11           +3

        9        Pfizer                     19          +10

        10       Biogen                     1            -9

        10       Novo Nordisk               8            -2

        12       Amgen                      13           +1

        13       Eli Lilly                  21           +8

        13       GlaxoSmithKline            16           +3

        15       Sanofi                     20           +5

        16       Allergan                               New

        17       Celgene                    10           -7

        18       Valeant                                New

        19       Bayer                      18           -1

        20       Otsuka                     14           -6

        20       Regeneron                  24           +4

        22       Boehringer Ingelheim       25           +3

        23       Eisai                      26           +3

        23       Teva                       30           +7

        25       Lundbeck                   27           +2

        26       Merck KGaA                 28           +2

        27       Sumitomo                               New

        28       Astellas                   23           -5

        29       UCB                        29       No change

        30       Shire                      22           -8

        31       Takeda                     5           -26

        32       Mylan                                  New

How did AstraZeneca catapult from 15th spot in 2017 all the way to the top of the Pharmaceutical Innovation Index?

A series of strategic decisions that helped generate a substantial amount of positive data for their pipeline began to stem the company’s downward trend since the loss of several patentexpirations between 2011 and 2017. AstraZeneca managed to launch five new medicines in 2017, across their primary therapy areas, the reportnoted.

IDEA Pharma’s CEO, Mike Rea said: “There is no gaming the Pharmaceutical Innovation Index -success is achieved by discovering and developing meaningfully great medicines and getting those medicines to market, and to patients. It is wonderful to see a company of AstraZeneca’s scale and history able to turnaround its fortunes in a relatively short period of time.”

At last report, AstraZeneca had about 1,500 employees in Delaware.

For a further look at this year’s Pharmaceutical Innovation Index, visit http://www.ideapharma.com/pii

Facebook Comments